Get the Stockscreener App
2.26
6.60%
0.14
After Hours:
2.29
0.03
+1.33%
Fractyl Health Inc stock is traded at $2.26, with a volume of 9.37M.
It is up +6.60% in the last 24 hours and up +61.43% over the past month.
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.
See More
Previous Close:
$2.12
Open:
$2.12
24h Volume:
9.37M
Relative Volume:
2.24
Market Cap:
$309.72M
Revenue:
-
Net Income/Loss:
$-56.85M
P/E Ratio:
-1.4496
EPS:
-1.559
Net Cash Flow:
-
1W Performance:
-1.74%
1M Performance:
+61.43%
6M Performance:
+18.32%
1Y Performance:
+18.95%
1-Day Range:
$2.1186
$2.39
1-Week Range:
$1.88
$2.445
52-Week Range:
$0.825
$3.03
Fractyl Health Inc Stock (GUTS) Company Profile
Name
Fractyl Health Inc
Sector
Industry
Phone
781-902-8800
Address
3 VAN DE GRAAFF DRIVE, BURLINGTON
Compare GUTS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GUTS
Fractyl Health Inc
|
2.26 | 290.53M | 0 | -56.85M | 0 | -1.559 |
|
VRTX
Vertex Pharmaceuticals Inc
|
447.38 | 114.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
748.71 | 78.80B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
396.04 | 51.80B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
847.05 | 53.08B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
166.55 | 42.33B | 447.02M | -1.18B | -906.14M | -6.1812 |
Fractyl Health Inc Stock (GUTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-15-25 | Initiated | H.C. Wainwright | Buy |
| Aug-28-25 | Initiated | Ladenburg Thalmann | Buy |
| Feb-28-24 | Initiated | Evercore ISI | Outperform |
| Feb-27-24 | Initiated | BofA Securities | Buy |
| Feb-27-24 | Initiated | Morgan Stanley | Overweight |
Fractyl Health Inc Stock (GUTS) Latest News
Will Fractyl Health Inc. stock deliver shareholder value2025 Stock Rankings & Daily Profit Focused Stock Screening - Улправда
What margin trends mean for Fractyl Health Inc. stockJuly 2025 Reactions & Reliable Volume Spike Alerts - Улправда
Fractyl Health, Inc. (NASDAQ:GUTS) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Fractyl Health Calls Tranche A Warrants - TipRanks
Fractyl Health Announces Call of Tranche A Warrants - TradingView — Track All Markets
Fractyl Health Announces Call of Tranche A Warrants Tied to August 2025 Public Offering Following Achievement of Clinical and Trading Milestones - The Manila Times
Fractyl Health calls Tranche A warrants for exercise or cancellation - Investing.com India
Fractyl Health (NASDAQ: GUTS) sets Dec. 30 deadline on Tranche A warrants - Stock Titan
Fractyl Health calls Tranche A warrants for exercise or cancellation By Investing.com - Investing.com Nigeria
Fractyl Health, Inc. Announces Call of Tranche A Common Stock Purchase Warrants for Cancellation and Cash Consideration - Quiver Quantitative
Fractyl Health (Nasdaq: GUTS) sets Dec. 30 cut-off for $1.05 Tranche A warrants - Stock Titan
Trend Report: Why Fractyl Health Inc stock remains resilientWeekly Trade Summary & Long-Term Growth Stock Strategies - moha.gov.vn
Fractyl Health Earnings Notes - Trefis
Is Fractyl Health Inc a good long term investmentSector Rotation Strategies & Low Risk Capital Growth Plans - earlytimes.in
Fractyl Health management to meet virtually with Needham - MSN
CEO Makes Bold Move with Major Stock Purchase in Fractyl Health! - TipRanks
Insider Buying: Fractyl Health (NASDAQ:GUTS) CEO Buys 10,416 Shares of Stock - MarketBeat
Rajagopalan, Fractyl Health CEO, buys $19998 in shares - Investing.com
Fractyl Health says procedure can maintain weight loss after stopping GLP-1 - MSN
Fractyl Health, Inc.: Promising Outlook with Revita DMR’s Long-term Efficacy and Market Potential - TipRanks
Fractyl Health's (GUTS) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
Fractyl Health stock maintains Buy rating at Canaccord on positive weight data - Investing.com Australia
Fractyl Health stock maintains Buy rating at Canaccord on positive weight data By Investing.com - Investing.com South Africa
Promising Data and Future Prospects Lead to Buy Rating for Fractyl Health, Inc. - TipRanks
Fractyl Health (GUTS) Stock Analysis Report | Financials & Insights - Benzinga
Breakout Zone: Why Fractyl Health Inc. stock is trending among retail tradersMarket Growth Summary & Risk Adjusted Buy and Sell Alerts - BỘ NỘI VỤ
Fractyl procedure sustains weight loss after GLP-1s - BioWorld MedTech
Biotech says one-time procedure helps patients keep weight off post-GLP-1 - The Business Journals
What's Going On With Fractyl Health Stock Tuesday?Fractyl Health (NASDAQ:GUTS) - Benzinga
Fractyl Health's Revita Procedure Helps Patients Keep Weight Off After Stopping GLP-1 Drugs - Sahm
Fractyl Health announces 6-month results from REVEAL-1 Cohort - TipRanks
Fractyl Health Says Revita Procedure Maintains Stable Weight After GLP-1 Discontinuation - marketscreener.com
Revita treatment shows stable weight in patients after GLP-1 discontinuation - Investing.com India
Fractyl Health Announces Positive REVEAL-1 Study Results - TipRanks
Fractyl Health Reports Positive 6-Month REVEAL-1 Results - TradingView — Track All Markets
Fractyl Health Reports Positive 6-Month REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure - The Manila Times
Fractyl Health Reports Positive 6-Month REVEAL-1 Open-Label Results Showing Sustained ... - Enidnews.com
Fractyl Health Reports Positive 6-Month REVEAL-1 Open-Label - GlobeNewswire
Will Fractyl Health Inc. stock maintain growth storyJuly 2025 Market Mood & Momentum Based Trading Ideas - Newser
Fractyl Health to Participate in the 8th Annual Evercore Healthcare Conference - The Manila Times
Fractyl Health (Nasdaq: GUTS) to join fireside chat at 8th Annual Evercore Healthcare Conference - Stock Titan
Fractyl Health’s Earnings Call Highlights Clinical and Financial Progress - MSN
Rate Cut: What margin trends mean for Fractyl Health Inc. stockEarnings Overview Report & AI Enhanced Execution Alerts - moha.gov.vn
Risk On: What margin trends mean for Fractyl Health Inc. stockQuarterly Portfolio Review & AI Forecasted Stock Moves - moha.gov.vn
Pharma News: Is Fractyl Health Inc. stock in correction or buying zone2025 Fundamental Recap & Trade Opportunity Analysis - BỘ NỘI VỤ
Fractyl Health, Inc. (NASDAQ:GUTS) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Canaccord Genuity Group Issues Positive Forecast for Fractyl Health (NASDAQ:GUTS) Stock Price - MarketBeat
Canaccord Genuity raises Fractyl Health stock price target on positive data By Investing.com - Investing.com Nigeria
Canaccord Genuity raises Fractyl Health stock price target on positive data - Investing.com Canada
Fractyl Health price target raised to $8 from $6 at Canaccord - TipRanks
Will Fractyl Health Inc. stock sustain high P E ratiosMarket Rally & Safe Entry Trade Reports - newser.com
Fractyl Health Inc Stock (GUTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.31%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):